Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cti Biopharma Corp (CTIC) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cti Biopharma Corp. Table 2 shows the detailed insider transactions. This company's CIK number is 891293.
Total stock buying since 2014: $25,251,450.
Total stock sales since 2014: $72,634,856.
Total stock option exercises since 2014: $1,190,126.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 0 | $0 | 265,746 | $1,596,467 | 265,746 | $243,044 |
| 2022 | 5,000 | $27,500 | 9,475,245 | $57,882,161 | 955,124 | $947,082 |
| 2021 | 2,003,500 | $5,005,337 | 2,000,000 | $7,000,000 | 0 | $0 |
| 2018 | 6,333,333 | $18,999,999 | 0 | $0 | 20,121 | $0 |
| 2017 | 0 | $0 | 14,600 | $46,965 | 187,045 | $0 |
| 2016 | 1,001,327 | $1,218,614 | 413,169 | $253,857 | 127,390 | $0 |
| 2015 | 0 | $0 | 2,302,027 | $3,574,885 | 0 | $0 |
| 2014 | 0 | $0 | 880,004 | $2,280,521 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-01 | 0 | $0 | 265,746 | $1,596,467 | 265,746 | $243,044 |
| 2022-12 | 0 | $0 | 111,963 | $672,070 | 111,963 | $102,912 |
| 2022-11 | 0 | $0 | 91,500 | $514,779 | 91,500 | $84,271 |
| 2022-10 | 0 | $0 | 900 | $5,625 | 900 | $852 |
| 2022-09 | 0 | $0 | 444,815 | $2,689,069 | 444,815 | $422,128 |
| 2022-08 | 5,000 | $27,500 | 8,500,000 | $52,020,000 | 0 | $0 |
| 2022-07 | 0 | $0 | 183,844 | $1,124,598 | 163,723 | $137,690 |
| 2022-06 | 0 | $0 | 142,223 | $856,020 | 142,223 | $199,229 |
| 2021-12 | 3,500 | $5,337 | 0 | $0 | 0 | $0 |
| 2021-04 | 2,000,000 | $5,000,000 | 0 | $0 | 0 | $0 |
| 2021-01 | 0 | $0 | 2,000,000 | $7,000,000 | 0 | $0 |
| 2018-02 | 6,333,333 | $18,999,999 | 0 | $0 | 0 | $0 |
| 2018-01 | 0 | $0 | 0 | $0 | 20,121 | $0 |
| 2017-09 | 0 | $0 | 14,600 | $46,965 | 0 | $0 |
| 2017-04 | 0 | $0 | 0 | $0 | 178,642 | $0 |
| 2017-01 | 0 | $0 | 0 | $0 | 8,403 | $0 |
| 2016-06 | 0 | $0 | 10,000 | $3,650 | 0 | $0 |
| 2016-05 | 0 | $0 | 10,000 | $4,470 | 0 | $0 |
| 2016-04 | 0 | $0 | 0 | $0 | 127,390 | $0 |
| 2016-03 | 0 | $0 | 338,169 | $185,832 | 0 | $0 |
| 2016-02 | 0 | $0 | 20,000 | $17,870 | 0 | $0 |
| 2016-01 | 1,001,327 | $1,218,614 | 35,000 | $42,035 | 0 | $0 |
| 2015-12 | 0 | $0 | 135,000 | $166,244 | 0 | $0 |
| 2015-11 | 0 | $0 | 50,000 | $61,200 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-01-24 | Fong James K (EVP & Chief Commercial Officer) | Sale | 100,000 | 6.00 | 600,000 |
| 2023-01-24 | Fong James K (EVP & Chief Commercial Officer) | Option Ex | 100,000 | .95 | 94,900 |
| 2023-01-03 | Craig Adam R (President and CEO) | Sale | 84,683 | 6.01 | 509,198 |
| 2023-01-03 | Craig Adam R (President and CEO) | Option Ex | 84,683 | .84 | 71,218 |
| 2023-01-03 | Kirske David (EVP, Chief Financial Officer) | Sale | 54,042 | 6.01 | 324,846 |
| 2023-01-03 | Kirske David (EVP, Chief Financial Officer) | Option Ex | 54,042 | .95 | 51,284 |
| 2022-12-30 | Craig Adam R (President and CEO) | Sale | 17,100 | 6.00 | 102,685 |
| 2022-12-30 | Craig Adam R (President and CEO) | Option Ex | 17,100 | .84 | 14,381 |
| 2022-12-30 | Kirske David (EVP, Chief Financial Officer) | Sale | 27,694 | 6.00 | 166,302 |
| 2022-12-30 | Kirske David (EVP, Chief Financial Officer) | Option Ex | 27,694 | .95 | 26,280 |
| 2022-12-29 | Craig Adam R (President and CEO) | Sale | 13,800 | 6.00 | 82,800 |
| 2022-12-29 | Craig Adam R (President and CEO) | Option Ex | 13,800 | .84 | 11,605 |
| 2022-12-29 | Kirske David (EVP, Chief Financial Officer) | Sale | 26,348 | 6.00 | 158,088 |
| 2022-12-29 | Kirske David (EVP, Chief Financial Officer) | Option Ex | 26,348 | .95 | 25,004 |
| 2022-11-08 | Metzger Michael A (Director) | Sale | 91,500 | 5.63 | 514,779 |
| 2022-11-08 | Metzger Michael A (Director) | Option Ex | 91,500 | .92 | 84,271 |
| 2022-10-03 | Kirske David (EVP, Chief Financial Officer) | Sale | 600 | 6.25 | 3,750 |
| 2022-10-03 | Kirske David (EVP, Chief Financial Officer) | Option Ex | 600 | .95 | 568 |
| 2022-09-30 | Kirske David (EVP, Chief Financial Officer) | Sale | 279,682 | 6.05 | 1,691,236 |
| 2022-09-30 | Kirske David (EVP, Chief Financial Officer) | Option Ex | 279,682 | .95 | 265,418 |
| 2022-09-29 | Kirske David (EVP, Chief Financial Officer) | Sale | 1,800 | 6.00 | 10,808 |
| 2022-09-29 | Kirske David (EVP, Chief Financial Officer) | Option Ex | 1,800 | .95 | 1,708 |
| 2022-09-16 | Kirske David (EVP, Chief Financial Officer) | Sale | 22,592 | 6.02 | 136,003 |
| 2022-09-16 | Kirske David (EVP, Chief Financial Officer) | Option Ex | 22,592 | .95 | 21,439 |
| 2022-08-16 | Craig Adam R (President and CEO) | Buy | 5,000 | 5.50 | 27,500 |
| 2022-08-09 | Lampert Mark N | Sale | 8,500,000 | 6.12 | 52,020,000 |
| 2022-07-07 | Metzger Michael A (Director) | Sale | 20,121 | 6.53 | 131,289 |
| 2022-07-06 | Craig Adam R (President and CEO) | Sale | 18,223 | 6.11 | 111,342 |
| 2022-07-06 | Craig Adam R (President and CEO) | Option Ex | 18,223 | .84 | 15,325 |
| 2022-07-05 | Metzger Michael A (Director) | Sale | 91,500 | 6.10 | 557,967 |
| 2022-07-05 | Metzger Michael A (Director) | Option Ex | 91,500 | .84 | 76,951 |
| 2022-07-05 | Craig Adam R (President and CEO) | Sale | 27,000 | 6.00 | 162,000 |
| 2022-07-05 | Craig Adam R (President and CEO) | Option Ex | 27,000 | .84 | 22,707 |
| 2022-07-01 | Craig Adam R (President and CEO) | Sale | 27,000 | 6.00 | 162,000 |
| 2022-07-01 | Craig Adam R (President and CEO) | Option Ex | 27,000 | .84 | 22,707 |
| 2022-06-17 | Kirske David (EVP, Chief Financial Officer) | Sale | 60,000 | 6.12 | 367,500 |
| 2022-06-17 | Kirske David (EVP, Chief Financial Officer) | Option Ex | 60,000 | 2.15 | 129,000 |
| 2022-06-14 | Kirske David (EVP, Chief Financial Officer) | Sale | 10,000 | 5.50 | 55,000 |
| 2022-06-14 | Kirske David (EVP, Chief Financial Officer) | Option Ex | 10,000 | .95 | 9,490 |
| 2022-06-03 | Craig Adam R (President and CEO) | Sale | 18,223 | 6.01 | 109,520 |
| 2022-06-03 | Craig Adam R (President and CEO) | Option Ex | 18,223 | .84 | 15,325 |
| 2022-06-02 | Craig Adam R (President and CEO) | Sale | 27,000 | 6.00 | 162,000 |
| 2022-06-02 | Craig Adam R (President and CEO) | Option Ex | 27,000 | .84 | 22,707 |
| 2022-06-01 | Craig Adam R (President and CEO) | Sale | 27,000 | 6.00 | 162,000 |
| 2022-06-01 | Craig Adam R (President and CEO) | Option Ex | 27,000 | .84 | 22,707 |
| 2021-12-02 | Craig Adam R (President and CEO) | Buy | 3,500 | 1.52 | 5,337 |
| 2021-04-01 | Lampert Mark N | Buy | 2,000,000 | 2.50 | 5,000,000 |
| 2021-01-07 | Orbimed Capital Gp Vi Llc | Sale | 2,000,000 | 3.50 | 7,000,000 |
| 2018-02-09 | Lampert Mark N | Buy | 6,333,333 | 3.00 | 18,999,999 |
| 2018-01-20 | Metzger Michael A (Director) | Option Ex | 20,121 | .00 | 0 |
| 2017-09-29 | Love Richard L (Director) | Sale | 976 | 3.20 | 3,123 |
| 2017-09-28 | Love Richard L (Director) | Sale | 13,624 | 3.22 | 43,842 |
| 2017-04-29 | Tuckson Reed Vaughn (Director) | Option Ex | 34,736 | .00 | 0 |
| 2017-04-29 | Telling Fred (Director) | Option Ex | 34,736 | .00 | 0 |
| 2017-04-29 | Love Richard L (Director) | Option Ex | 34,736 | .00 | 0 |
| 2017-04-29 | Nudelman Phillip M Phd (Director) | Option Ex | 39,698 | .00 | 0 |
| 2017-04-28 | Perry Matthew D | Option Ex | 34,736 | .00 | 0 |
| 2017-01-11 | Perry Matthew D | Option Ex | 8,403 | .00 | 0 |
| 2016-06-24 | Bianco James A (President and CEO) | Sale | 10,000 | .36 | 3,650 |
| 2016-05-27 | Bianco James A (President and CEO) | Sale | 10,000 | .45 | 4,470 |
| 2016-04-29 | Tuckson Reed Vaughn (Director) | Option Ex | 63,695 | .00 | 0 |
| 2016-04-29 | Telling Fred (Director) | Option Ex | 63,695 | .00 | 0 |
| 2016-03-28 | Bianco James A (President and CEO) | Sale | 10,000 | .49 | 4,940 |
| 2016-03-21 | Bianco James A (President and CEO) | Sale | 318,169 | .55 | 174,992 |
| 2016-03-04 | Plunkett Matthew (EVP, Chief Business Officer) | Sale | 10,000 | .59 | 5,900 |
| 2016-02-26 | Bianco James A (President and CEO) | Sale | 10,000 | .63 | 6,290 |
| 2016-02-04 | Plunkett Matthew (EVP, Chief Business Officer) | Sale | 10,000 | 1.16 | 11,580 |
| 2016-01-29 | Singer Jack W (EVP, Chief Scientific Officer) | Sale | 15,000 | 1.19 | 17,775 |
| 2016-01-29 | Bianco James A (President and CEO) | Sale | 10,000 | 1.20 | 12,010 |
| 2016-01-08 | Lampert Mark N | Buy | 367,547 | 1.22 | 447,304 |
| 2016-01-07 | Lampert Mark N | Buy | 633,780 | 1.22 | 771,310 |
| 2016-01-04 | Plunkett Matthew (EVP, Chief Business Officer) | Sale | 10,000 | 1.23 | 12,250 |
| 2015-12-30 | Bianco James A (President and CEO) | Sale | 100,000 | 1.26 | 125,699 |
| 2015-12-28 | Bianco James A (President and CEO) | Sale | 10,000 | 1.29 | 12,920 |
| 2015-12-18 | Singer Jack W (EVP Global Medical Affairs) | Sale | 15,000 | 1.18 | 17,655 |
| 2015-12-04 | Plunkett Matthew (EVP, Corporate Development) | Sale | 10,000 | 1.00 | 9,970 |
| 2015-11-27 | Singer Jack W (EVP, Global Medical Affairs) | Sale | 15,000 | 1.21 | 18,150 |
| 2015-11-27 | Bianco James A (President and CEO) | Sale | 10,000 | 1.23 | 12,250 |
| 2015-11-19 | Bianco Louis A (EVP, Finance & Administration) | Sale | 15,000 | 1.13 | 16,950 |
| 2015-11-04 | Plunkett Matthew (EVP, Corporate Development) | Sale | 10,000 | 1.39 | 13,850 |
| 2015-10-30 | Bianco James A (President and CEO) | Sale | 260,000 | 1.35 | 351,520 |
| 2015-10-29 | Bianco Louis A (EVP, Finance & Administration) | Sale | 10,000 | 1.41 | 14,090 |
| 2015-10-23 | Singer Jack W (EVP, Global Medical Affairs) | Sale | 15,000 | 1.62 | 24,315 |
| 2015-10-22 | Bianco Louis A (EVP, Finance & Administration) | Sale | 10,000 | 1.58 | 15,800 |
| 2015-10-05 | Plunkett Matthew (EVP, Corporate Development) | Sale | 10,000 | 1.52 | 15,230 |
| 2015-09-30 | Singer Jack W (EVP, Global Medical Affairs) | Sale | 25,000 | 1.45 | 36,350 |
| 2015-09-30 | Love Richard L (Director) | Sale | 13,660 | 1.46 | 19,916 |
| 2015-09-30 | Bianco James A (President and CEO) | Sale | 200,000 | 1.45 | 289,400 |
| 2015-09-30 | Nudelman Phillip M Phd (Director) | Sale | 135,620 | 1.45 | 196,649 |
| 2015-09-29 | Plunkett Matthew (EVP, Corporate Development) | Sale | 75,000 | 1.42 | 106,575 |
| 2015-09-29 | Singer Jack W (EVP, Global Medical Affairs) | Sale | 75,000 | 1.41 | 105,450 |
| 2015-09-29 | Bianco Louis A (EVP, Finance & Administration) | Sale | 170,000 | 1.42 | 241,060 |
| 2015-09-29 | Bianco James A (President and CEO) | Sale | 400,000 | 1.43 | 570,800 |
| 2015-09-29 | Nudelman Phillip M Phd (Director) | Sale | 14,380 | 1.45 | 20,865 |
| 2015-09-25 | Singer Jack W (EVP, Global Medical Affairs) | Sale | 15,000 | 1.63 | 24,510 |
| 2015-09-24 | Plunkett Matthew (EVP, Corporate Development) | Sale | 75,869 | 1.56 | 118,583 |
| 2015-09-24 | Bianco Louis A (EVP, Finance & Administration) | Sale | 10,000 | 1.52 | 15,200 |
| 2015-09-04 | Plunkett Matthew (EVP, Corporate Development) | Sale | 10,000 | 1.54 | 15,390 |
| 2015-08-28 | Singer Jack W (EVP, Global Medical Affairs) | Sale | 15,000 | 1.58 | 23,700 |
| 2015-08-04 | Plunkett Matthew (EVP, Corporate Development) | Sale | 10,000 | 1.84 | 18,450 |
| 2015-07-24 | Singer Jack W (EVP, Global Medical Affairs) | Sale | 15,000 | 1.91 | 28,695 |
| 2015-07-23 | Bianco Louis A (EVP, Finance & Administration) | Sale | 10,000 | 1.91 | 19,100 |
| 2015-07-06 | Plunkett Matthew (EVP, Corporate Development) | Sale | 10,000 | 1.95 | 19,500 |
| 2015-06-26 | Singer Jack W (EVP, Global Medical Affairs) | Sale | 15,000 | 2.07 | 31,095 |
| 2015-06-25 | Bianco Louis A (EVP, Finance & Administration) | Sale | 10,000 | 2.18 | 21,800 |
| 2015-06-04 | Plunkett Matthew (EVP, Corporate Development) | Sale | 10,000 | 2.06 | 20,650 |
| 2015-05-22 | Singer Jack W (EVP, Global Medical Affairs) | Sale | 15,000 | 1.74 | 26,160 |
| 2015-05-21 | Bianco Louis A (EVP, Finance & Administration) | Sale | 10,000 | 1.80 | 18,000 |
| 2015-05-04 | Plunkett Matthew (EVP, Corporate Development) | Sale | 10,000 | 1.86 | 18,580 |
| 2015-04-24 | Singer Jack W (EVP, Global Medical Affairs) | Sale | 15,000 | 1.96 | 29,385 |
| 2015-04-23 | Bianco Louis A (EVP,Finance and Administration) | Sale | 10,000 | 1.93 | 19,300 |
| 2015-04-06 | Plunkett Matthew (EVP, Corporate Development) | Sale | 16,569 | 1.89 | 31,315 |
| 2015-03-23 | Plunkett Matthew (EVP, Corporate Development) | Sale | 59,130 | 1.97 | 116,190 |
| 2015-03-23 | Bianco James A (President and CEO) | Sale | 175,199 | 1.95 | 341,112 |
| 2015-03-20 | Singer Jack W (EVP, Global Medical Affairs) | Sale | 67,600 | 1.94 | 131,144 |
| 2015-03-20 | Bianco Louis A (EVP, Finance & Administration) | Sale | 63,000 | 1.94 | 122,094 |
| 2015-03-04 | Plunkett Matthew (EVP, Corporate Development) | Sale | 12,000 | 2.42 | 28,980 |
| 2015-02-05 | Bianco Louis A (EVP, Finance & Administration) | Sale | 10,000 | 2.23 | 22,250 |
| 2015-02-04 | Plunkett Matthew (EVP, Corporate Development) | Sale | 12,000 | 2.23 | 26,712 |
| 2015-01-08 | Bianco Louis A (EVP, Finance & Administration) | Sale | 10,000 | 2.32 | 23,230 |
| 2015-01-05 | Plunkett Matthew (EVP, Corporate Development) | Sale | 12,000 | 2.36 | 28,296 |
| 2014-12-19 | Bianco James A (President and CEO) | Sale | 30,000 | 2.45 | 73,620 |
| 2014-12-18 | Bianco James A (President and CEO) | Sale | 10,000 | 2.40 | 23,980 |
| 2014-12-04 | Plunkett Matthew (EVP, Corporate Development) | Sale | 12,000 | 2.23 | 26,820 |
| 2014-12-04 | Bianco Louis A (EVP, Finance & Administration) | Sale | 10,000 | 2.25 | 22,530 |
| 2014-11-06 | Bianco Louis A (EVP, Finance & Administration) | Sale | 10,000 | 2.37 | 23,720 |
| 2014-11-04 | Plunkett Matthew (EVP, Corporate Development) | Sale | 12,000 | 2.39 | 28,667 |
| 2014-10-06 | Plunkett Matthew (EVP, Corporate Development) | Sale | 12,000 | 2.40 | 28,740 |
| 2014-09-23 | Plunkett Matthew (EVP, Corporate Development) | Sale | 51,818 | 2.54 | 131,617 |
| 2014-09-22 | Plunkett Matthew (EVP, Corporate Development) | Sale | 51,817 | 2.56 | 132,651 |
| 2014-09-22 | Bianco James A (President and CEO) | Sale | 307,068 | 2.53 | 776,574 |
| 2014-09-19 | Bianco Louis A (EVP, Finance & Administration) | Sale | 145,000 | 2.61 | 378,015 |
| 2014-09-04 | Plunkett Matthew (EVP, Corporate Development) | Sale | 27,301 | 2.48 | 67,679 |
| 2014-08-15 | Bianco James A (President and CEO) | Sale | 40,000 | 2.54 | 101,720 |
| 2014-08-04 | Plunkett Matthew (EVP, Corporate Development) | Sale | 12,000 | 2.49 | 29,832 |
| 2014-07-10 | Bianco Louis A (EVP, Finance & Administration) | Sale | 10,000 | 2.73 | 27,300 |
| 2014-07-07 | Plunkett Matthew (EVP, Corporate Development) | Sale | 12,000 | 2.88 | 34,620 |
| 2014-06-27 | Bianco James A (President and CEO) | Sale | 50,000 | 2.84 | 142,000 |
| 2014-06-05 | Bianco Louis A (EVP, Finance & Administration) | Sale | 10,000 | 2.97 | 29,710 |
| 2014-06-04 | Plunkett Matthew (EVP, Corporate Development) | Sale | 12,000 | 3.02 | 36,276 |
| 2014-06-04 | Bianco James A (President and CEO) | Sale | 55,000 | 2.99 | 164,450 |
Insider trading activities including stock purchases, stock sales, and option exercises of CTIC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cti Biopharma Corp (symbol CTIC, CIK number 891293) see the Securities and Exchange Commission (SEC) website.